Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,209.00    19.00 (0.87%)
Bid:
2,212.00
Ask:
2,214.00
Spread: 2.00 (0.09%)
Market Cap: £22.41b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Update on Action valuation

30 Jun 2016 07:00

RNS Number : 7191C
3i Group PLC
30 June 2016
Β 

30 June 2016

Β 

Β 

3i Group plc

Update on Action valuation

Since the publication of 3i Group plc's ("3i" or "the Group") financial results for the year to 31 March 2016, 3i has received a number of approaches in respect of Action, the Group's largest portfolio investment.

Β 

Action continues to grow strongly and, based on trading to mid-June, is performing on a trajectory similar to its 2015 performance with a similar level of like-for-like sales growth. Action is currently also on track to open materially more new stores this year than it did last year.

Β 

In light of the third-party interest in Action and its continuing growth and financial trajectory, the Board of 3i has decided to increase the book value of its investment in Action to Β£1,464 million1 after liquidity discount as at 30 June 2016 (31 March 2016: Β£902 million). This implies a post discount run-rate EBITDA multiple of 18.2x applied to the run-rate earnings as at 31 March 20162. The book valuation of Β£1,464 million amounts to a less than 15x projected run-rate EBITDA as at 31 December 20162 on the assumption that Action continues to grow on its current trajectory for the remainder of this calendar year.

Β 

3i is actively engaged in the further development of Action and is not intending to sell its investment or organise a flotation of Action in the near future.

Β 

We will publish our Q1 performance update on 27 July 2016, which will include this adjustment and the results of our quarterly portfolio valuation.

Β 

Notes

1. Action's valuation currency is euros. The GBP equivalents at 30 June 2016 in this update have been calculated at a currency exchange rate of €1.2168:Β£1.

Β 

2. Action is valued using a multiple of its run-rate earnings for the 12 months to the quarter end preceding the reporting period. The valuation uplift to Β£1,464 million at 30 June 2016 is calculated using run-rate earnings to 31 March 2016. The valuation as at 31 March 2017 will be calculated using run-rate earnings to 31 December 2016.

Β 

- Ends -

Β 

For further information, please contact:

Β 

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

Β 

Toby Bates

Interim Communications DirectorTel: 020 7975 3032

Β 

Β 

About 3i Group

Β 

3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

Β 

The financial information in this update is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Although this update has been prepared based on reasonable assumptions, any statements about the future outlook of 3i or its investments may be influenced by factors that could cause actual outcomes and results to be materially different.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCPGUGPQUPQGRB
Date   Source Headline
19th Dec 20134:42 pmRNSHolding(s) in Company
19th Dec 20134:36 pmRNSDirector/PDMR Shareholding
12th Dec 201311:34 amRNSHolding(s) in Company
9th Dec 201311:23 amRNSHolding(s) in Company
9th Dec 201311:08 amRNSBlocklisting Interim Review
5th Dec 201310:26 amRNSHolding(s) in Company
29th Nov 20133:01 pmRNSDirector/PDMR Shareholding
29th Nov 20132:53 pmRNSTotal Voting Rights
29th Nov 20132:46 pmRNSDirector/PDMR Shareholding
27th Nov 201310:28 amRNSHolding(s) in Company
26th Nov 20134:21 pmRNSDirector/PDMR Shareholding
26th Nov 20134:16 pmRNSDirector/PDMR Shareholding
26th Nov 20133:05 pmRNSHolding(s) in Company
18th Nov 201311:15 amRNSHolding(s) in Company
15th Nov 201310:31 amRNSDirector/PDMR Shareholding
14th Nov 20133:19 pmRNSHolding(s) in Company
14th Nov 20131:34 pmRNSDoc re. 2013 Half Yearly Report
14th Nov 20137:00 amRNSHalf Yearly Report
12th Nov 20139:13 amRNSDirectorate Change
11th Nov 20137:00 amRNSCompletion of acquisition
6th Nov 201311:02 amRNSHolding(s) in Company
5th Nov 20134:02 pmRNSHolding(s) in Company
31st Oct 20131:59 pmRNSTotal Voting Rights
31st Oct 20131:53 pmRNSDirector/PDMR Shareholding
23rd Oct 201311:28 amRNSHolding(s) in Company
7th Oct 20133:12 pmRNSHolding(s) in Company
3rd Oct 201311:55 amRNSPortfolio Update
2nd Oct 201311:21 amRNSHolding(s) in Company
30th Sep 20133:27 pmRNSTotal Voting Rights
30th Sep 20133:18 pmRNSDirector/PDMR Shareholding
24th Sep 20138:00 amRNSPrivate Equity Capital Markets Seminar
19th Sep 201310:40 amRNSHolding(s) in Company
16th Sep 201312:13 pmRNSHolding(s) in Company
13th Sep 201310:37 amRNSHolding(s) in Company
6th Sep 20134:54 pmRNSDirector/PDMR Shareholding
4th Sep 20132:11 pmRNSHolding(s) in Company
30th Aug 20134:46 pmRNSTotal Voting Rights
30th Aug 20134:45 pmRNSDirector/PDMR Shareholding
7th Aug 201311:06 amRNSDirector/PDMR Shareholding
31st Jul 20134:38 pmRNSTotal Voting Rights
31st Jul 20134:34 pmRNSDirector/PDMR Shareholding
30th Jul 201310:39 amRNSDirector/PDMR Shareholding
26th Jul 20132:21 pmRNSDirector/PDMR Shareholding
18th Jul 20134:52 pmRNSDoc re. AGM Resolutions
18th Jul 20134:44 pmRNSResult of AGM
18th Jul 20137:01 amRNSAnnual General Meeting
18th Jul 20137:00 amRNSInterim Management Statement
9th Jul 201311:55 amRNSDTR 6.3.5
4th Jul 20131:25 pmRNSPortfolio Update
28th Jun 20132:52 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.